Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2002
06/27/2002WO2002050032A1 Naphthalene derivatives which bind to the ep4 receptor
06/27/2002WO2002050031A1 Indole derivatives
06/27/2002WO2002049993A2 High affinity small molecule c5a receptor modulators
06/27/2002WO2002049648A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
06/27/2002WO2002022602A3 Triazole compounds useful as protein kinase inhibitors
06/27/2002WO2002010154A3 Substituted heterocyclic amides
06/27/2002WO2002009648A3 Antimicrobial biaryl compounds
06/27/2002WO2001095856A3 Urea derivative useful as an anti-cancer agent and process for preparing same
06/27/2002WO2001082858A3 Novel compounds for the treatment of inflammatory and cardiovascular diseases
06/27/2002US20020082280 Method of inhibiting neoplastic cells with benzimidazole derivatives
06/27/2002US20020082278 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases
06/27/2002US20020082270 Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases
06/27/2002US20020082268 Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof
06/27/2002US20020082260 Isoindolin-1-one-substituted propionamide glucokinase activators which increase insulin secretion in the treatment of type II diabetes
06/27/2002US20020082259 Triazine compounds
06/27/2002US20020082256 Compounds useful as anti-inflammatory agents
06/27/2002CA2431767A1 Substituted pyrrolidines as ccr-3 receptor antagonists
06/27/2002CA2431592A1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
06/27/2002CA2431588A1 Benzylamine derivatives and their use as thrombin inhibitors
06/26/2002EP1216994A2 Tricyclic antidepressant derivatives and immunoassay
06/26/2002EP1216285A1 Fluorescent maleimides and uses thereof
06/26/2002EP1216248A2 Triazolopyrimidine derivatives
06/26/2002EP1216240A1 Amide compounds
06/26/2002EP1216239A1 Piperazine derivatives as 5-ht1b antagonists
06/26/2002EP1216234A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
06/26/2002EP1216231A2 INHIBITORS OF FACTOR Xa
06/26/2002EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
06/26/2002EP1216228A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
06/26/2002EP0929548B1 Substituted carbamoyl triazoles and their use as herbicides
06/26/2002EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists
06/26/2002EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
06/26/2002CN1355792A process for preparation of substituted pyrimidines
06/26/2002CN1355790A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives
06/26/2002CN1086578C Sulfonamides and their use
06/25/2002US6410791 Salbutamol; respiratory system disorders
06/25/2002US6410750 Phosphorylase inhibitor; anticholesterol agents; hypotensive agents; antiarthritic agents
06/25/2002US6410740 Heterocyclylmethyl-substituted pyrazol derivatives
06/25/2002US6410739 Indole derivatives as 5-HT1 agonists
06/25/2002US6410733 Anticoagulants
06/25/2002US6410562 Hypoglycemic imidazoline compounds
06/20/2002WO2002048117A1 Quinazolinone derivatives
06/20/2002WO2002048115A2 Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests
06/20/2002WO2002048114A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents
06/20/2002WO2002048106A2 Isoindolin-1-one glucokinase activators
06/20/2002WO2002047690A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
06/20/2002WO2002020495A3 Inhibitors of glycogen synthase kinase 3
06/20/2002WO2001090102A3 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
06/20/2002WO2000067734A3 Use of phthalazine derivatives
06/20/2002US20020077487 As labeling reagents for a variety of biological applications
06/20/2002US20020077483 Preparing a azole compound on a solid support resin, cleaving the compound from the solid support resin by nucleophilic substitution to further substituting by alkylation reaction
06/20/2002US20020077339 Chemokine receptor binding heterocyclic compounds
06/20/2002US20020077338 HIV protease inhibitors
06/20/2002US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis
06/20/2002DE10063116A1 Azinylsulfonylimidazole Azinylsulfonylimidazoles
06/20/2002DE10061541A1 New arylamino-substituted dihydropyrimidinone derivatives, useful as broad-spectrum antibacterial agents with strong activity against Gram positive bacteria
06/20/2002CA2431406A1 Quinazolinone derivatives
06/20/2002CA2430151A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents
06/19/2002EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation
06/19/2002EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
06/19/2002EP1214300A2 Rate-controlled particles
06/19/2002EP0754061B1 New oral pharmaceutical dosage form
06/19/2002CN1354749A Use of selective antagonists of 1b-adrenergic receptor for improvement of sexual dysfunction
06/19/2002CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine
06/19/2002CN1086386C Multi-drug resistance modifier
06/18/2002US6407256 Cyano-pyrrole, cyano-imidazole, cyano-pyrazole, and cyano-triazole compounds as factor Xa inhibitors
06/18/2002US6407254 For organic polymers
06/18/2002US6407244 Antiproliferative agent
06/18/2002US6407129 Azole compounds, their production and their use
06/18/2002US6407109 Antiepiletic, antidepressant, and anxiolytic agents; psychological and nervous system disorders
06/18/2002US6407106 For therapy of inflammatory disturbances of the gastrointestinal tract
06/18/2002US6407103 Potent enzyme inhibitors of cyclin-dependent kinases relating to the catalytic subunits cdk1-9 and their regulatory subunits cyclins a-h; antiproliferative, -carcinogenic and -tumor agents; viricides; modulators of dna/rna biosynthesis
06/18/2002US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
06/18/2002US6407101 Progesterone receptor antagonists; contraceptives, hormone replacement therapy; breast and prostate cancer treatment; menopause
06/18/2002US6407094 Glutamate receptor antagonists
06/18/2002US6407087 UCF116 derivatives
06/18/2002US6407080 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
06/18/2002CA2238140C Imidazole, triazole and tetrazole derivatives
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
06/13/2002WO2002046183A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
06/13/2002WO2002046182A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
06/13/2002WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
06/13/2002WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
06/13/2002WO2002046165A1 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
06/13/2002WO2002046158A2 Piperidine/piperazine-type inhibitors of p38 kinase
06/13/2002WO2002046151A1 Delta 1-pyrrolines used as pesticides
06/13/2002WO2002045652A2 Tyrosine kinase inhibitors
06/13/2002WO2002026706A3 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
06/13/2002WO2002016362A3 Nitrogenous heterocyclic compounds
06/13/2002WO2002016361A3 Nitrogenous heterocyclic compounds
06/13/2002WO2002016360A3 Nitrogenous heterocyclic compounds
06/13/2002WO2002006221A3 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
06/13/2002WO2001098277A3 Substituted bicyclic derivatives for the treatment of abnormal cell growth
06/13/2002WO2001090104A3 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
06/13/2002WO2001079198B1 Pyrazoles for inhibiting protein kinase
06/13/2002WO2001072721A3 Synergistic methods and compositions for treating cancer
06/13/2002US20020072616 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
06/13/2002US20020072614 For therapy of cardiovascular, cerebrovascular, respiratory and renal disorders
06/13/2002US20020072603 Novel IL-5 inhibiting 6-azauracil derivatives